<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32754560</PMID><DateRevised><Year>2020</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-2360</ISSN><JournalIssue CitedMedium="Print"><Volume>8</Volume><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>Frontiers in pediatrics</Title><ISOAbbreviation>Front Pediatr</ISOAbbreviation></Journal><ArticleTitle>Prevalence and Management of Severe Hand, Foot, and Mouth Disease in Xiangyang, China, From 2008 to 2013.</ArticleTitle><Pagination><StartPage>323</StartPage><MedlinePgn>323</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">323</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fped.2020.00323</ELocationID><Abstract><AbstractText>Therapeutic strategies for severe hand, foot, and mouth disease (HFMD) are currently either inconsequent or deficient in evidence. We retrospectively surveyed HFMD outbreaks in Xiangyang from June 2008 to December 2013. HFMD is staged from I to V according to clinical severity. Severe HFMD is defined as a case involving the central nervous system (CNS). We analyzed risk factors for fatality of severe cases and compared the efficiency and outcome of some therapies by binary logistic regression. The overall HFMD cases included 637 (1.26%) severe cases and 38 fatalities (0.075%). Analyses indicate that age (&lt;3 years), enterovirus 71 (+), autonomic nervous system dysregulation, pulmonary edema/hemorrhage, C-reactive protein (CRP) (&gt;40 mg/L), and cardiac troponin I (&gt;0.04 ng/ml) are risk factors for fatality (all <i>P</i> &lt; 0.05). Intravenous immunoglobulin (IVIG) and mechanical ventilation applied only in early stage IV significantly improved HFMD progression (both <i>P</i> &lt; 0.05) with odds ratios of 0.24 (95% CI: 0.10-0.57) and 0.01 (95% CI: 0.00-0.10), respectively. Neither methylprednisolone nor milrinone administered in any stage made any significant difference on mortality (all <i>P</i> &gt; 0.05). Precise recognition of the severe HFMD cases in early stage IV and prompt IVIG and mechanical ventilation application may reduce mortality. Mechanical ventilation training programs and dispatch of specialists to hospitals where there is no chance of transferring critical cases to the severe HFMD designated hospitals are two key measures to reduce fatality.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Liu and Qi.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, The Second School of Clinical Medicine, Affiliated Baoan Hospital of Shenzhen, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, The Second Affiliated Hospital of Shenzhen University, Shenzhen, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qi</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Affiliated Baoan Hospital of Shenzhen, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Pediatr</MedlineTA><NlmUniqueID>101615492</NlmUniqueID><ISSNLinking>2296-2360</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">contagious disease</Keyword><Keyword MajorTopicYN="N">coxsackievirus A16</Keyword><Keyword MajorTopicYN="N">hand, foot, mouth disease</Keyword><Keyword MajorTopicYN="N">human enterovirus 71</Keyword><Keyword MajorTopicYN="N">lung-protective ventilation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>12</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>6</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>7</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32754560</ArticleId><ArticleId IdType="pmc">PMC7366859</ArticleId><ArticleId IdType="doi">10.3389/fped.2020.00323</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ventarola D, Bordone L, Silverberg N. Update on hand-foot-and-mouth disease. Clin Dermatol. (2015) 33:340&#x2013;6. 10.1016/j.clindermatol.2014.12.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clindermatol.2014.12.011</ArticleId><ArticleId IdType="pubmed">25889136</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. (2010) 9:1097&#x2013;105. 10.1016/S1474-4422(10)70209-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70209-X</ArticleId><ArticleId IdType="pubmed">20965438</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. (2010) 10:778&#x2013;90. 10.1016/S1473-3099(10)70194-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Li XW, Ni X, Qian SY, Wang Q, Jiang RM, Xu WB, et al. . Chinese guidelines for the diagnosis and treatment of hand, foot and mouth disease (2018 edition). World J Pediatr. (2018) 14:437&#x2013;47. 10.1007/s12519-018-0189-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-018-0189-8</ArticleId><ArticleId IdType="pubmed">30280313</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang YK, Li N, Yang JZ, Deng B, Xie RH, Shu S, et al. . Epidemiologic characteristics of hand-foot-mouth disease in Guiyang between 2008 and 2010. Zhongguo Dang Dai Er Ke Za Zhi. (2012) 14:195&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">22433407</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MK, Chan PK, Ho II, Lai WM. Enterovirus infection among patients admitted to hospital in Hong Kong in 2010: epidemiology, clinical characteristics, and importance of molecular diagnosis. J Med Virol. (2013) 85:1811&#x2013;7. 10.1002/jmv.23663</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.23663</ArticleId><ArticleId IdType="pubmed">23824683</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing W, Liao Q, Viboud C, Zhang J, Sun J, Wu JT, et al. . Hand, foot, and mouth disease in China, 2008-12: an epidemiological study. Lancet. (2014) 14:308&#x2013;18. 10.1016/S1473-3099(13)70342-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(13)70342-6</ArticleId><ArticleId IdType="pmc">PMC4035015</ArticleId><ArticleId IdType="pubmed">24485991</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun LM, Wu SL, Tan XH, Li H, Yang F, Zeng HR, et al. . Epidemiological characteristics of coxsackie virus A16 caused hand foot and mouth disease cases in guangdong province, 2012-2016. Zhonghua Liu Xing Bing Xue Za Zhi. (2018) 39:342&#x2013;6. 10.3760/cma.j.issn.0254-6450.2018.03.018</Citation><ArticleIdList><ArticleId IdType="doi">10.3760/cma.j.issn.0254-6450.2018.03.018</ArticleId><ArticleId IdType="pubmed">29609251</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Bao H, Zhang X, Zhai M, Bao X, Wang D, et al. . Epidemiological and genetic analysis concerning the non-enterovirus 71 and non-coxsackievirus A16 causative agents related to hand, foot and mouth disease in anyang city, henan province, china, from 2011 to 2015. J Med Virol. (2017) 89:1749&#x2013;58. 10.1002/jmv.24847</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.24847</ArticleId><ArticleId IdType="pubmed">28480969</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Q, Xing XS, Wu Y, Liao QH, Liu GP, Jiang XQ, et al. . Hand, foot and mouth disease in Hubei province, 2009-2015: an epidemiological and etiological study. Zhonghua Liu Xing Bing Xue Za Zhi. (2017) 38:441&#x2013;5. 10.3760/cma.j.issn.0254-6450.2017.04.006</Citation><ArticleIdList><ArticleId IdType="doi">10.3760/cma.j.issn.0254-6450.2017.04.006</ArticleId><ArticleId IdType="pubmed">28468059</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian SY, Li XW. Epidemiology and management development of hand-foot-and-mouth disease in Chinese mainland: a ten-year review. Zhonghua Er Ke Za Zhi. (2018) 56:321&#x2013;3. 10.3760/cma.j.issn.0578-1310.2018.05.001</Citation><ArticleIdList><ArticleId IdType="doi">10.3760/cma.j.issn.0578-1310.2018.05.001</ArticleId><ArticleId IdType="pubmed">29783814</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical Experts Group of the Ministry of Health for Hand, Foot and Mouth Disease . Experts consensus on rescue and treatment of severe cases with enterovirus 71 (EV71) infection. Zhonghua Er Ke Za Zhi. (2011) 49:675&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">22176902</ArticleId></ArticleIdList></Reference><Reference><Citation>Amato MB, Barbas CS, Medeiros DM, Magaldi RB, Schettino GP, Lorenzi-Filho G, et al. . Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Eng J Med. (1998) 338:347&#x2013;54. 10.1056/NEJM199802053380602</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199802053380602</ArticleId><ArticleId IdType="pubmed">9449727</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu RH, Li J, Qu XF, Xu YJ, Qu NY, Feng XC. Clinical characteristics and prognostic factors of children with critical hand-foot-mouth disease treated with mechanical ventilation. Zhongguo Dang Dai Er Ke Za Zhi. (2015) 17:249&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">25815494</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng G, Cao J, Yu J, Zhang Z, Liu Q, Chen J. Risk factors for death in children with critical and severe hand-foot-and-mouth disease in chongqing, China: an observational study. Medicine. (2017) 96:e8934. 10.1097/MD.0000000000008934</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000008934</ArticleId><ArticleId IdType="pmc">PMC5728875</ArticleId><ArticleId IdType="pubmed">29245260</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, Lei HY, Huang MC, Wu JM, Chen CT, Wang JN, et al. . Therapeutic efficacy of milrinone in the management of enterovirus 71-induced pulmonary edema. Pediatr Pulmonol. (2005) 39:219&#x2013;23. 10.1002/ppul.20157</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.20157</ArticleId><ArticleId IdType="pubmed">15635619</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang M, Wang XC. Clinical research of early, enough methylprednisone combined with immunoglobulin in treatment of severe hand-foot-mouth disease. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. (2013) 27:363&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">24645324</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, Lei HY, Huang MC, Su LY, Lin HC, Yu CK, et al. . Modulation of cytokine production by intravenous immunoglobulin in patients with enterovirus 71-associated brainstem encephalitis. J Clin Virol. (2006) 37:47&#x2013;52. 10.1016/j.jcv.2006.05.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2006.05.009</ArticleId><ArticleId IdType="pubmed">16861032</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng M, Zheng X, Wei R, Zhang N, Zhu K, Xu B, et al. . The cytokine and chemokine profiles in patients with hand, foot and mouth disease of different severities in shanghai, China, 2010. PLoS Negl Trop Dis. (2013) 7:e2599. 10.1371/journal.pntd.0002599</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0002599</ArticleId><ArticleId IdType="pmc">PMC3868519</ArticleId><ArticleId IdType="pubmed">24367714</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y, Yang J, Zeng G, Shen T, Fontaine RE, Zhang L, et al. . Risk factors for critical disease and death from hand, foot and mouth disease. Pediatr Infect Dis J. (2014) 33:966&#x2013;70. 10.1097/INF.0000000000000319</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000000319</ArticleId><ArticleId IdType="pubmed">24577041</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi MH, Wong SC, Mohan A, Podin Y, Perera D, Clear D, et al. . Identification and validation of clinical predictors for the risk of neurological involvement in children with hand, foot, and mouth disease in Sarawak. BMC Infect Dis. (2009) 9:3. 10.1186/1471-2334-9-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-9-3</ArticleId><ArticleId IdType="pmc">PMC2637878</ArticleId><ArticleId IdType="pubmed">19152683</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, Liu CC, Tseng HW, Wang JR, Huang CC, Chen YJ, et al. . Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications. Clin Infect Dis. (1999) 29:184&#x2013;90. 10.1086/520149</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/520149</ArticleId><ArticleId IdType="pubmed">10433583</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu HK, Lin TY, Hsia SH, Chiu CH, Huang YC, Tsao KC, et al. . Prognostic implications of myoclonic jerk in children with enterovirus infection. J Microbiol Immunol Infect. (2004) 37:82&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">15181488</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, Qiu W, Xu C, Wang J. A spatiotemporal mixed model to assess the influence of environmental and socioeconomic factors on the incidence of hand, foot and mouth disease. BMC Public Health. (2018) 18:274. 10.1186/s12889-018-5169-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-018-5169-3</ArticleId><ArticleId IdType="pmc">PMC5819665</ArticleId><ArticleId IdType="pubmed">29463224</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>